Healthcare Triangle is trading at $0.45, down 6.91%, amid uncertainty over its Nasdaq delisting appeal after a determination tied to its failure to meet the $1.00 minimum bid-price requirement.
- The company intended to request a hearing by October 8; the SEC filing confirms its intention, not that an appeal was filed.
- Nasdaq said trading could be suspended October 12 absent an appeal; a timely hearing request would stay suspension pending review. The filing gives no October 12 confirmation of appeal filing or suspension.